Virbac continues to increase its footprint in the livestock market, launching TENOTRYL (enrofloxacin) injectable solution for use in cattle and swine. The product was approved by the FDA on March 28 and will be available beginning in July. The injectable solution comes in 100-, 250- and 500-ml vials.

This launch is the third product brought to the livestock health market by Virbac over the past six months. 

"Launching three products over the past six months is the best proof of our commitment to sustainably grow our offerings in the livestock health sector and to continuously propose more solutions to take care of the health of these animals, even in a context of rising feed and energy costs," says Fabrice Payot, vice president, Livestock Health, Virbac North America.

Regarding distribution, Virbac markets its cattle products via its own direct sales force; whereas for swine, the firm is partnering with Pharmgate. Under this arrangement, Pharmgate, with a very robust sales and technical services division, represents Virbac to swine veterinarians and producers across the U.S.

"The partnership with Virbac is working well and it is always great to see the range growing. The three new products naturally complement the Pharmgate range and we foresee more synergies and health programs to be developed in the near future," says Chad Smith, incoming vice president, Global Sales and Marketing, Pharmgate Animal Health.

Source: Virbac, which is solely responsible for the information provided, and wholly owns the information. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.